Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters

FEBS Journal

Volumn 275, Issue 10, 2008, Pages 2617-2631

  Masson, Patrick ^a   Froment, Marie Thérèse ^a   Gillon, Emilie ^a   Nachon, Florian ^a   Lockridge, Oksana ^b   Schopfer, Lawrence M ^b  

^a CENTRE DE RECHERCHES   (France)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aryl acylamidase; Benzalkonium; Butyrylcholinesterase; Serotonin; Tyramine

Indexed keywords

ACETANILIDE DERIVATIVE; ARYL ACYLAMIDASE; BENZALKONIUM; CHOLINESTERASE; ESTER DERIVATIVE; ESTERASE; PROPANIL; SEROTONIN; TYRAMINE;

ARTICLE; CATALYSIS; HYDROLYSIS; KINETICS; PRIORITY JOURNAL;

ACETANILIDES; AMIDOHYDROLASES; BENZALKONIUM COMPOUNDS; BINDING SITES; BUTYRYLCHOLINESTERASE; ENZYME ACTIVATION; ESTERS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SEROTONIN; TYRAMINE;

EID: 42649137543     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06409.x     Document Type: Article

References (74)

1. Massoulié J, Pezzementi L, Bon S, Krejci E Vallette FM (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41, 31 91.
2. Darvesh S, Hopkins DA Geula C (2003) Neurobiology of butyrylcholinesterase. Nature Neurosci 4, 131 138.
3. Clitherow JW, Mitchard M Harper NJ (1963) The possible biological function of pseudocholinesterase. Nature 199, 1000 1001.
4. Kutty KM Payne RH (1994) Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J Clin Lab Anal 8, 247 250.
5. Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG Lockridge O (2003) Acetylcholinesterase knockouts establish central cholinergic pathway and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110, 627 639.
6. Grisaru D, Sternfeld M, Eldor A, Glick D Soreq H (1999) Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 264, 672 686.
7. Mack A Robitzki A (2000) The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5′-butyrylcholinesterase study. Prog Neurobiol 60, 607 628.
8. Jameson RR, Seidler FJ Slotkin TA (2007) Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon. Environ Health Perspect 115, 65 70.
9. Munoz FJ, Aldunate R Inestrosa NC (1999) Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. NeuroReport 10, 3621 3625.
10. Bon CL Greenfield SA (2003) Bioactivity of a peptide derived from acetylcholinesterase: electrophysiological characterization in guinea-pig hippocampus. Eur J Neurosci 17, 1991 1995.
11. Cousin X, Strähle U Chatonnet A (2005) Are there non-catalytic functions of acetylcholinesterases? Lessons from mutant animal models BioEssays 27, 189 200.
12. Checler F, Grassi J Vincent J-P (1994) Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J Neurochem 62, 756 763.
13. Balasubramanian AS Banumathy CD (1993) Noncholinergic functions of cholinesterases. FASEB J 7, 1354 1358.
14. Boopathy R Layer PG (2004) Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Prot J 23, 325 333.
15. Guillozet AL, Smiley JF, Mash DC Mesulam MM (1997) Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol 42, 909 918.
16. Satoh T (2005) Toxicological implications of esterases - from molecular structures to functions. Toxicol Appl Pharmacol 207, S11 S18.
17. Potter PM Wadkins RM (2006) Carboxylesterases - detoxifying enzymes and targets for drug therapy. Curr Med Chem 13, 1045 1054.
18. Liederer BM Borchardt RT (2006) Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 95, 1177 1195.
19. Saxena A, Sun W, Luo C, Myers TM, Koplovitz I, Lenz DE Doctor BP (2006) Bioscavengers for protection from toxicity of organophosphorus compounds. J Mol Neurosci 30, 145 147.
20. Junge W Krisch K (1975) The carboxylesterases/amidases of mammalian liver and their possible significance. CRC Crit Rev Food Sci Nutr 3, 371 434.
21. Satoh T (1987) Role of carboxylesterases in xenobiotic metabolism. Rev Biochem Toxicol 8, 155 181.
22. George ST Balasubramanian AS (1981) The aryl acylamidases and their relationship to cholinesterases in human serum, erythrocyte and liver. Eur J Biochem 121, 177 186.
23. Hsu LL (1982) Brain aryl acylamidase. Int J Biochem 14, 1037 1042.
24. Matsushima M, Inoue H, Ichinose M, Tsukada S, Miki K, Kurokawa K, Takahashi T Takahashi K (1991) The nucleotide and deduced amino acid sequences of porcine liver proline-β-naphthylamidase. Evidence for identity with carboxylesterase. FEBS Lett 293, 37 41.
25. Manoharan I Boopathy R (2006) Diisopropylfluorophosphate-sensitive aryl acylamidase activity of fatty acid free human serum albumin. Arch Biochem Biophys 452, 186 188.
26. Masson P, Froment M-T, Darvesh S, Schopfer LM Lockridge O (2007) Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate. J Enz Inhib Med Chem 22, 463 469.
27. Cahill GM Besharse JC (1989) Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc Natl Acad Sci USA 86, 1098 1102.
28. Cassida J Quistad GB (2004) Organophosphate toxicology: safety aspects of non acetylcholinesterase secondary targets. Chem Toxicol 17, 983 998.
29. Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps J-C Nachon F (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 278, 41141 41147.
30. Majundar R Balasubramanian AS (1984) Chemical modification of acetylcholinesterase from eel and basal ganglia: effect on the acetylcholinesterase and aryl acylamidase activities. Biochemistry 23, 4088 4093.
31. Boopathy R Balasubramanian AS (1985) Chemical modification of the bifunctional pseudocholinesterase. Effect on the pseudocholinesterase and aryl acylamidase activities. Eur J Biochem 151, 351 360.
32. Costagli C Galli A (1998) Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease. Biochem Pharmacol 55, 1733 1737.
33. Rajeh RV, Biju T, Indumathi M Boopathy R (2007) Does aryl acyl amidase of butyrylcholinesterase have any physiological function? In Proceedings of the IXth International Meeting on Cholinesterases, Suzhou, China, May 6-10, (Tsim KWK Jiang H-L, eds) p. 32. Hong Kong University of Science and Technology, Hong Kong, China.
34. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R Martin E (2006) On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem 14, 4586 4599.
35. Masson P, Froment M-T, Gillon E, Nachon F, Darvesh S Schopfer LM (2007) Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides. Biochim Biophys Acta 1774, 1139 1147.
36. Tsujita T Okuda H (1983) Carboxylesterases in rat and human sera and their relationship to serum aryl acylamidases and cholinesterases. Eur J Biochem 133, 215 220.
37. Jayanthi LD, Balasubramanian N Balasubramanian AS (1992) Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid. Clin Chim Acta 205, 157 166.
38. Weitnauer E, Robitzki A Layer PG (1998) Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum. Neurosci Lett 254, 153 156.
39. Bhanumathy CD, Rao RV Balasubramanian AS (1998) Serum butyrylcholinesterase of non-human primate shows amine sensitive aryl acyl amidase and metallopeptidase activities and characteristics similar to those of the human serum enzyme. Indian J Biochem Biophys 35, 146 156.
40. Darvesh S, Walsh R Martin E (2003) Enantiomer affects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol Neurobiol 23, 93 100.
41. Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K Martin E (2003) Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord 17, 117 126.
42. Jaganathan L Boopathy R (2000) Distinct effect of benzalkonium on the esterase and aryl acylamidase activities of butyrylcholinesterase. Bioorg Chem 28, 242 251.
43. Rao RV, Gnanamuthu C Balasubramanian AS (1989) Human cerebrospinal fluid acetylcholinesterase and butyrylcholinesterase. Evidence for identity between the serum and cerebrospinal fluid butyrylcholinesterase. Clin Chim Acta 183, 135 146.
44. Masson P, Legrand P, Bartels CF, Froment M-T, Schopfer LM Lockridge O (1997) Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase. Biochemistry 36, 2266 2277.
45. Masson P, Adkins S, Gouet P Lockridge O (1993) Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant. J Biol Chem 268, 14329 14341.
46. Cléry C, Heiber-Langer I, Channac L, David L, Balny C Masson P (1995) Substrate dependence of amiloride- and soman-induced conformation changes of butyrylcholinesterase as evidenced by high-pressure perturbation. Biochim Biophys Acta 1250, 19 28.
47. Stojan J, Golicnik G, Froment M-T, Estour F Masson P (2002) Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion. Eur J Biochem 269, 1154 1161.
48. Kucukkilinc T Ozer I (2007) Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes. Arch Biochem Biophys 461, 294 298.
49. Masson P, Froment M-T, Bartels C Lockridge O (1996) Asp70 in the peripheral anionic site of human butyrylcholinesterase. Eur J Biochem 235, 36 48.
50. Berman HA Leonard K (1990) Ligand exclusion on acetylcholinesterase. Biochemistry 29, 10640 10649.
51. Segel IH (1975) Enzyme kinetics. J. Wiley & Sons, New York, NY, pp. 161 272 (reprinted in 1993, Wiley Classic Library Edition, ISBN 0-471-30309-7).
52. Masson P, Xie W, Froment M-T, Levitsky V, Fortier P-L, Albaret C Lockridge O (1999) Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Biochim Biophys Acta 1433, 281 293.
53. Masson P, Xie W, Froment M-T Lockridge O (2001) Effects of mutations of active site residues and amino acids interacting with the Ω loop on substrate activation of butyrylcholinesterase. Biochim Biophys Acta 1544, 166 176.
54. Stojan J, Brochier L, Alies C, Colletier JP Fournier D (2004) Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate. Eur J Biochem 271, 1364 1371.
55. Colletier JP, Fournier D, Greenblatt HM, Sojan J, Sussman JL, Silman I Weik M (2006) Structural insights into substrate traffic and inhibition in acetylcholinesterase. EMBO J 25, 2746 2756.
56. Saxena A, Redman AMG, Jiang X, Lockridge O Doctor BP (1997) Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Biochemistry, 36, 14642 14651.
57. Ilieva S, Hadjieva B Galabov B (2002) Theory supplemented by experiment. Electronic effects on the rotational stability of the amide group in p-substituted acetanilides. J Org Chem 67, 6210 6215.
58. Masson P, Froment M-T, Fortier P-L, Visicchio J-E, Bartels CF Lockridge O (1998) Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters. Biochim Biophys Acta 1387, 41 52.
59. Millard CB, Koellner G, Ordentlich A, Shafferman A, Silman I Sussman JL (1999) Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J Am Chem Soc 121, 9883 9884.
60. Kaplan D, Barak D, Ordentlich A, Kronman C, Velan B Shafferman A (2004) Is aromaticity essential for trapping the catalytic histidine 447 in human acetylcholinesterase? Biochemistry 43, 3129 3136.
61. Hörnberg H, Tunemalm AK Ekström F (2007) Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state. Biochemistry 46, 4815 4825.
62. Kereveur A, Callebert J, Humbert M, Herve P, Simonneau G, Launay JM Drouet L (2000) High plasma serotonin concentration levels in primary pulmonary hypertension: effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 20, 2233 2239.
63. Faraj BA, Fulenwider JT Rypins EB (1979) Tyramine kinetics and metabolism in cirrhosis. J Clin Invest 64, 413 420.
64. Boutin JA, Audinot V, Ferry G Delagrange P (2005) Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 26, 412 419.
65. Li B, Sedlacek M, Manoharam I, Boopathy R, Duysen EG, Masson P Lockridge O (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70, 1673 1684.
66. Satoh T Hosokawa M (2006) Structure, function and regulation of carboxylesterases. Chem-Biol Interact 162, 195 211.
67. Lockridge O, Schopfer LM, Winger G Woods JH (2005) Large-scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity. J Med Chem Biol Radiol Def 3, doi :.
68. Jaganathan L Boopathy R (2000) A direct method to visualise the arylacylamidase activity on cholinesterases in polyacrylamide gels. BMC Biochem doi :.
69. Johnson JL, Cusack B, Davies MP, Fauq A Rosenberry TL (2003) Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. Biochemistry 42, 5438 5452.
70. Kolkenbrock S, Parschat K, Beermann B, Hinz HJ Fetzner S (2006) N-acetylanthranilate amidase from Arthrobacter nitroguajacolicus Rü61a, an α/β-hydrolase-fold protein active towards aryl-acylamides and esters, and properties of its cysteine-deficient variant. J Bacteriol 188, 8430 8440.
71. Hoagland RE Graf G (1971) Nitroacetanilides as chromogenic substrate for assaying de-acetylating activity: the isolation and partial purification of aryl acylamidases from erepsin and tulip. Enzymologia 41, 313 319.
72. Ellman GL, Courtney KD, Andres V Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7, 88 95.
73. Amitai G, Moorad D, Adani R Doctor BP (1998) Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. Biochem Pharmacol 56, 293 299.
74. Cornish-Bowden A (1974) A graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 137, 143 144.